Literature DB >> 8843417

Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo.

L Tremblay1, W Hauck, L T Nguyen, P Allard, F Landry, A Chapdelaine, S Chevalier.   

Abstract

Focal adhesion kinase (pp125FAK) is a nonreceptor protein tyrosine kinase transducing signals initiated through integrin activation triggered by cell/extracellular matrix (ECM) interactions. To examine its role in epithelial cell adhesion, proliferation, and differentiation, we have studied pp125FAK expression, activity, and association with paxillin in two canine prostate models in which these functions can be selectively regulated: in vitro by vitronectin (VN) and serum factors, and in vivo by sex steroids. Kinetic studies revealed that the adhesion and spreading of prostatic epithelial cells in primary culture was regulated by serum VN and a natural ECM containing VN produced by prostate cells. While barely detectable in freshly isolated prostate cells, proliferating cells, after 72 h in culture, expressed higher levels of FAK mRNA (8-fold), pp125FAK (50-fold), and paxillin (50-fold). In prostate cells with a reduced growth rate after 2 weeks in culture, we observed a decrease in pp125FAK (4-fold) and its transcript (3-fold), but no change in paxillin. In vivo, both proteins were undetectable in normal and hyperplastic glands composed of a well differentiated epithelium, and in prostates restored by androgen supplementation. In contrast, pp125FAK and paxillin were up-regulated by androgen deprivation (castration) and further increased by estrogen treatment, which yielded metaplastic prostates mostly composed of proliferating basal epithelial cells. Moreover, both proteins were constitutively phosphorylated on tyrosine in the metaplastic prostate, as well as in proliferating cultured cells. Together, these results demonstrate that pp125FAK expression is regulated at the protein and mRNA levels and forms active signaling complexes with paxillin when epithelial cells in contact with ECM proteins are induced to proliferate in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843417     DOI: 10.1210/mend.10.8.8843417

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  9 in total

Review 1.  Extracellular matrix and integrin signalling: the shape of things to come.

Authors:  N J Boudreau; P L Jones
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

2.  Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix.

Authors:  L Yang; J Guerrero; H Hong; D B DeFranco; M R Stallcup
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

3.  Prostate cancer cell surface-associated keratin 8 and its implications for enhanced plasmin activity.

Authors:  Melissa Hirsch Kuchma; Joo Hee Kim; Mark T Muller; Philip A Arlen
Journal:  Protein J       Date:  2012-03       Impact factor: 2.371

4.  Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.

Authors:  Silke Kaulfuss; Michal Grzmil; Bernhard Hemmerlein; Paul Thelen; Stefan Schweyer; Jürgen Neesen; Lukas Bubendorf; Andrew G Glass; Hubertus Jarry; Bernd Auber; Peter Burfeind
Journal:  Mol Endocrinol       Date:  2008-05-01

5.  Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.

Authors:  Rebecca S Arnold; Carrie Q Sun; Jendai C Richards; Galina Grigoriev; Ilsa M Coleman; Peter S Nelson; Chia-Ling Hsieh; Jae K Lee; Zhiheng Xu; Andre Rogatko; Adeboye O Osunkoya; Majd Zayzafoon; Leland Chung; John A Petros
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

6.  Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

Authors:  Shibu Thomas; Maurizio Chiriva-Internati; Girish V Shah
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

Review 7.  Targeting tyrosine kinases and autophagy in prostate cancer.

Authors:  Hsing-Jien Kung
Journal:  Horm Cancer       Date:  2010-12-02       Impact factor: 3.869

8.  FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.

Authors:  LaTonia Taliaferro-Smith; Elaine Oberlick; Tongrui Liu; Tanisha McGlothen; Tiffanie Alcaide; Rachel Tobin; Siobhan Donnelly; Rachel Commander; Erik Kline; Ganji Purnachandra Nagaraju; Lauren Havel; Adam Marcus; Rita Nahta; Ruth O'Regan
Journal:  Oncotarget       Date:  2015-03-10

9.  DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.

Authors:  Samia B Bachmann; Sandra C Frommel; Rosalba Camicia; Hans C Winkler; Raffaella Santoro; Paul O Hassa
Journal:  Mol Cancer       Date:  2014-05-27       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.